Aspirin resistance: a revival of platelet aggregation tests?

This publication has 44 references indexed in Scilit:

• Pharmacokinetic and Pharmacodynamic Differences Between Two Low Dosages of Aspirin May Affect Therapeutic Outcomes
  Clinical Pharmacokinetics, 2003
• Might Proton Pump Inhibitors Prevent the Antiplatelet Effects of Low- or Very Low-Dose Aspirin?
  Archives of internal medicine (1960), 2002
• Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Increased synthesis of thromboxane A2 and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitus
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 2001
• Habitual smoking causes an abnormality in platelet thromboxane A 2 metabolism and results in an altered susceptibility to aspirin effects
  Platelets, 2000
• Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance
  The Lancet, 1999
• Platelet-Aggregation Response to Single or Paired Aggregating Stimuli after Low-Dose Aspirin
  New England Journal of Medicine, 1986
• Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
  Circulation, 1985
• Pharmacologic modulation of arachidonic acid metabolism in man. A minireview with emphasis on radioimmunological methods used to quantitate drug effects
  International Journal of Immunopharmacology, 1982